ICD-10 Specific code P39.1: Neonatal conjunctivitis and dacryocystitis
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Neonatal conjunctivitis and dacryocystitis |
French
|
Conjonctivite et dacryocystite néonatales |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | XVI | Certain conditions originating in the perinatal period | |
| 2 | P35-P39 | Infections specific to the perinatal period | |
| 3 | P39 | Other infections specific to the perinatal period | |
| 4 | P39.1 | Neonatal conjunctivitis and dacryocystitis |
Indicated medicines
| Active Ingredient |
|---|
|
Boric Acid is a weakly acidic hydrate of boric oxide with mild antiseptic, antifungal, and antiviral properties. The exact mechanism of action of boric acid is unknown; generally cytotoxic to all cells. It is used in the treatment of yeast infections and cold sores. |
|
Ketotifen is a histamine H1-receptor antagonist. In vivo animal studies and in vitro studies suggest the additional activities of mast cell stabilisation and inhibition of infiltration, activation and degranulation of eosinophils. |
|
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |